Mandarin gains 2.2x from Italy-China deal

The cross-border private equity firm has sold pharmaceutical manufacturing company IMA after helping establish its presence in the Chinese market.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this